Insulin glargine and lixisenatide and Quinupristin and Dalfopristin
Determining the interaction of Insulin glargine and lixisenatide and Quinupristin and Dalfopristin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: dalfopristin / quinupristin
Brand name: Synercid
Synonyms: Dalfopristin and quinupristin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Quinupristin and dalfopristin Intravenous
- Insulin glargine and lixisenatide-QuinZyme coenzyme Q-10
- Insulin glargine and lixisenatide-Quiphile
- Insulin glargine and lixisenatide-Quit Nicotine Gum - Mint
- Insulin glargine and lixisenatide-Qutenza
- Insulin glargine and lixisenatide-Qvar
- Quinupristin and Dalfopristin-Insulin glargine and lixisenatide Subcutaneous
- Quinupristin and Dalfopristin-Insulin glargine, recombinant Subcutaneous
- Quinupristin and Dalfopristin-Insulin glulisine
- Quinupristin and Dalfopristin-Insulin Glulisine (Cartridges and Pens)
- Quinupristin and Dalfopristin-Insulin Glulisine (Vials)
- Quinupristin and Dalfopristin-Insulin glulisine Subcutaneous